Related Experiment Videos
Immunologic studies in presumed amniotic fluid embolism.
M D Benson1, H Kobayashi, R K Silver
1Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, Illinois, USA. michael.benson@home.com
Obstetrics and Gynecology
|March 29, 2001
Summary
Complement activation, not anaphylaxis, appears involved in amniotic fluid embolism. This study found low complement levels in patients, suggesting a key role for this immune response in the condition.
Area of Science:
- Immunology
- Obstetrics
- Pathophysiology
Background:
- Amniotic fluid embolism (AFE) is a rare but often fatal obstetric emergency.
- The exact pathophysiological mechanisms underlying AFE remain incompletely understood.
- Potential roles of mast cell degranulation (anaphylaxis) and complement activation have been hypothesized.
Purpose of the Study:
- To investigate the involvement of immunologic mechanisms, specifically mast cell degranulation and complement activation, in the pathophysiology of amniotic fluid embolism.
- To differentiate between anaphylaxis and complement activation as potential drivers of AFE.
Main Methods:
- A case series design was employed, including nine women diagnosed with presumed amniotic fluid embolism.
- A control group of 22 women with normal labor was included for comparison.
- Maternal peripartum serum levels of complement components (C3 and C4), serum tryptase, urinary histamine, and serum fetal antigen (sialyl Tn) were measured.
Main Results:
- Serum tryptase and urinary histamine levels were negative in AFE patients, ruling out anaphylaxis.
- Elevated levels of fetal antigen (sialyl Tn) were observed in seven of nine AFE patients.
- All tested AFE patients (eight) exhibited significantly lower serum complement levels (C3 and C4) compared to controls (P=.018 for C3, P=.012 for C4).
Conclusions:
- Serologic findings strongly suggest that complement activation plays a significant role in the mechanism of amniotic fluid embolism.
- The study's laboratory data did not support the involvement of mast cell degranulation (anaphylaxis) in the pathophysiology of AFE.